XML 110 R74.htm IDEA: XBRL DOCUMENT v3.24.0.1
Interests in entities - Text Details (Detail)
€ in Millions
 12 Months Ended
Dec. 31, 2023
EUR (€)
Dec. 31, 2022
EUR (€)
Dec. 31, 2021
EUR (€)
Interests in entities [Line Items]      
Presumed significant influence, voting rights 50.00%    
Number of consolidated subsidiaries not wholly owned 4 4  
Revenue € 18,169 € 17,827 € 17,156
Profit (loss) (463) [1] (1,605) [2] € 3,323 [2]
Net cash outflow for acquisitions 3    
Gain (loss) recognized as a result of remeasuring to fair value equity interest in associate upon loss of significant influence 23    
Share of profit (loss) of associates accounted for using equity method 51    
Impairment loss (impairment gain and reversal of impairment loss) determined in accordance with IFRS 9 33    
Currency translation differences   1,866  
Philips Medical Capital LLC [Member]      
Interests in entities [Line Items]      
Stake in unconsolidated structured entity 27 29  
Associates [member]      
Interests in entities [Line Items]      
Impairment loss (impairment gain and reversal of impairment loss) determined in accordance with IFRS 9 58    
Currency translation differences (21) (22)  
Subsidiaries with material non-controlling interests [member]      
Interests in entities [Line Items]      
Revenue 492 472  
Profit (loss) € 27 € 28  
Consolidated structured entities [member]      
Interests in entities [Line Items]      
Materiality threshold on group sales, income from operations or net income 5.00%    
Bottom of range [member]      
Interests in entities [Line Items]      
Presumed significant influence, voting rights 20.00%    
Top of range [member]      
Interests in entities [Line Items]      
Presumed significant influence, voting rights 50.00%    
[1] Shareholders in this table refers to shareholders of Koninklijke Philips N.V. Per share calculations have been adjusted retrospectively for all periods presented to reflect the issuance of shares for the share dividend in respect of 2022.
[2] Shareholders in this table refers to shareholders of Koninklijke Philips N.V. Per share calculations have been adjusted retrospectively for all periods presented to reflect the issuance of shares for the share dividend in respect of 2022.